期刊文献+

维吾尔族妇女宫颈病变及人乳头状瘤病毒感染与抗原处理相关转运体TAP1和TAP2基因启动子甲基化的关系 被引量:7

Relationship between TAP gene promoter methylation and cervical lesions with HPV infection in Uyghur women
原文传递
导出
摘要 目的探讨维吾尔族妇女宫颈病变及人乳头状瘤病毒(HPV)感染与抗原处理相关转运体(TAP)基因启动子区甲基化水平的关系和意义。方法利用专业软件设计TAP1和TAP2基因启动子区含CpG岛特异性PCR引物,对宫颈癌SiHa细胞DNA进行亚硫酸氢盐修饰、目的片段扩增、质粒载体克隆和测序,确定该区域所含CpG序列的甲基化情况。收集维吾尔族妇女15例正常宫颈上皮、30例宫颈鳞状上皮内肿瘤形成(CIN)和33例宫颈鳞癌患者的新鲜组织标本共78例,提取DNA,采用MassArrayDNA技术平台(质谱分析)定量分析TAP1和TAP2基因启动子甲基化水平,同时以HPV分型芯片鉴定HPV亚型,分析基因甲基化与HPV感染的关系。结果(1)TAP1和TAP2基因相应目的片段各含23个和8个CpG位点,在宫颈癌SiHa细胞基因组DNA中,分别有5个和8个CpG位点发生甲基化。宫颈病变病理过程伴随着TAP1基因CpG片段甲基化水平的改变,其在宫颈鳞癌和CIN组织的甲基化率[(0.048±0.039)和(0.037±0.026)]高于正常宫颈上皮组织(0.035±0.029),差异有统计学意义(P〈0.05)。尽管TAP2基因甲基化水平也发生了相应改变,但其差异无统计学意义(P〉0.05)。HPV分型芯片检出13种HPV基因型,其中HPV16所占比率为66.7%(52/78),HPV16亚型阳性与宫颈病变进程及TAP1基因甲基化率的升高趋势呈正相关(X^2=6.08,P=0.039)。结论TAP1基因启动子区CpG岛甲基化是宫颈癌病变的一种特异性改变,与HPV16感染可能存在密切关系。 Objective To study the relationship between TAP (transporter associated with antigen processing) gene promoter regional methylation level and cervical lesions with HPV infection in Uyghur women. Methods A specialized software was used to design specific primers of CpG island fragments of TAP1 and TAP2 gene promoter for PCR amplification, bisulfitemodified SiHa cancer cell DNA for PCR amplification, cloning and sequencing analysis to obtain the relevant information on the gene base sequence mcthylation of CpG sites. Seventy-eight fresh cervical tissue samples from Uyghur women with cervicitis (number = 15 ), cervical intraepithelial neoplasia (CIN, number = 30 ) and cervical squamous cell carcinoma ( number = 33 ) were collected. The methylation level of TAP1 and TAP2 gene promoter regions was detected using MassArray DNA technology. HPV infection status was determined by HPV gene chips. The relationship between CpG-island methylation of gene promoter regions and HPV infection was then analyzed. Results Each TAP1 and TAP2 gene corresponding target fragment contained 23 and 8 CpG sites. There were 5 and 8 CpG sites methylation occurred in SiHa cervical cancer cells genomic DNA respectively. The TAP1 methylation level increased steadily with the severity of cervical lesions. The methylation levels in cervical squamous cell carcinoma and CIN (0. 048 ± 0. 039 and 0. 037± 0. 026, respectively) were higher than that of normal cervical tissue (0. 035 ± 0. 029, P 〈 0. 05 ). Although TAP2 gene methylation level also demonstrated similar changes, the difference however was not statistically significant ( P 〉 0. 05 ). HPV gene chip detected 13 HPV genotypes, with HPV16 infection rate being 66. 7% (52/78). The methylated proportion of TAPI positively correlated with HPV16 infection ( X^2 = 6. 08, P = 0. 039 ). Conclusion TAP1 methylation is a remarkable phenomenon occurring in a range of cervical lesions and significantly associated with cervical HPV infection.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2012年第7期438-442,共5页 Chinese Journal of Pathology
基金 国家自然科学基金(81060164) 新疆维吾尔自治区自然科学青年基金(2009211B14)
关键词 维吾尔族 宫颈疾病 DNA甲基化 乳头状瘤病毒 Uygur nationality Cervix diseases DNA methylation Papillomavirus, human
  • 相关文献

参考文献21

  • 1Boname JM, May JS, Stevenson PG. The murine gamma- herpesvirus-68 MK3 protein causes TAP degradation independentof MHC class I heavy chain degxadation. Eur J Immunol, 2005, 35( 1 ) :171-179.
  • 2de la Salle H, Saulquin X, Mansour I, et al. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP). Clin Exp Immunol, 2002,128 ( 3 ) :525-531.
  • 3Seliger B, Ritz U, Ferrone S. Molecular mechanisms of HLA class 1 antigen abnormalities following viral infection and transformation. lnt J Cancer, 2006,118( 1 ) :129-138.
  • 4Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 2004, 429 (6990) : 457-463.
  • 5Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 2002, 21 ( 35 ) :5427-5440.
  • 6Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 2004, 21 (2) :137-148.
  • 7Groothuis TA, Griekspoor AC, Neijssen JJ, et al. MHC class I alleles and their exploration of the antigen-processing machinery. Immunol Rev, 2005, 207: 60-76.
  • 8Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol, 2006, 6 ( 11 ) : 836- 848.
  • 9Dissemond J, Busch M, Kothen T, et al. Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma. Cancer Lett, 2004, 203(2) :225-231.
  • 10Kamarashev J, Ferrone S, Seifert B, et al. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J cancer, 2001,95( 1 ) :23-28.

二级参考文献10

共引文献3

同被引文献67

  • 1Ming-Yao Wu Mao-Huai Chen Ying-Rui Liang Guo-Zhao Meng Huan-Xing Yang Chu-Xiang Zhuang Department of Pathology,Shantou University Medical College,Shantou 515031,Guangdong Province,China Supported by the National Natural Science Foundation of China,No.39670298..Experimental and clinic-opathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma[J].World Journal of Gastroenterology,2001,7(4):490-495. 被引量:20
  • 2拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 3凌斌.子宫颈癌诊断与治疗的新进展[J].中国实用妇科与产科杂志,2007,23(1):23-25. 被引量:66
  • 4Forouzanfar MH,Foreman KJ,Delossantos AM,Lozano R,Lopez AD,Murray C J,Naghavi M.Breast and cervical cancer in 187 countries between 1980and 2010:a systematic analysis[J] .Lancet 2011;378(9801):1461-1484.
  • 5Romaguera D,Vergnaud AC,Peeters PH,Van Gils CH,Chan DS,Ferrari P,Romieu I,Jenab M,Slimani N,Clavel-Chapelon F,Norat T.Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer Results from the EPIC study[J] .Am J Clin Nutr 2012 ; 96(1):150-163.
  • 6Van der MeideWF,Snellenberg S,Meijer CJ,Baalbergen A,Helmerhorst TJ,van der Sluis WB,Snijders PJ,Steenbergen RD.Promoter methylation analysis of WNT/beta-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix[J] .Gynecol Oncol 2011 ; 123(1):116-122.
  • 7Noordhuis MG Fehrmann RS,Wisman GB,Nijhuis ER,Van Zanden J J,Moerland PD,Ver Loren Van Themaat E,Voiders HH,Kok M,ten Hoor KA et al:Involvement of the TGF·beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer[J] .Clin CancerRes,2011 ; 17(6):1317-1330.
  • 8王芳,邓新粮.新辅助化疗对不同分型HPV宫颈癌近期疗效的临床分析[J] .医药前沿,2013,(13):42-43,44.
  • 9Harria HA. Estrogen receptor-beta:recent lessons from in vivo studies[J].Molecular Endocrinology,2007,(01):1-13.doi:10.1210/me.2005-0459.
  • 10Wisman GB,Nijhuis ER,Hoque MO. Assessment of gene promoter hypermethylation for detection of cervical neoplasia[J].International Journal of Cancer,2006,(08):1908-1914.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部